Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Gun Violence Trauma
  • Maternal Mortality
  • Hospital Food
  • Medicaid Work Requirements
  • Visa Program Delays

TRENDING TOPICS:

  • Gun Violence Trauma
  • Maternal Mortality
  • Hospital Food
  • Medicaid Work Requirements
  • Visa Program Delays

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jul 24 2017

Full Issue

States Urged To Sue Drug Companies Over Painkiller Epidemic By Lawyers Who Drove Tobacco Litigation

The Wall Street Journal reports on a one-time attorney general who is aiding in lawsuits filed by Mississippi and Ohio against pharmaceutical makers. In another story on the business front of the drug crisis, McKesson's board will be greeted by picketing teamsters organized by the father of an overdose victim.

The Wall Street Journal: Lawyers Hope To Do To Opioid Makers What They Did To Big Tobacco

The legal front widening against makers of opioid painkillers has something in common with landmark tobacco litigation of the 1990s: attorney Mike Moore. As Mississippi’s attorney general in 1994, Mr. Moore filed the first state lawsuit against tobacco companies, saying they harmed public-health systems by misrepresenting smoking’s dangers. He helped marshal the subsequent spate of state litigation and then the talks that led to a $246 billion settlement. (Whalen, 7/23)

Bloomberg: Overdose Victim's Dad Rallies Teamsters In Fight With McKesson 

When McKesson’s board and executives gather near Dallas for their annual shareholders meeting on July 26, they’ll be greeted by a throng of picketing Teamsters. Representatives of the union, which owns more than $30 million of McKesson shares, will call on investors to reject the company’s executive-pay plan and for the board to claw back some of Chief Executive Officer John Hammergren’s compensation. (Melin, 7/21)

State efforts to combat the epidemic are reported from Massachusetts, New Jersey, Virginia, Colorado and Connecticut —

The Associated Press: Tool To Help Police In Opioid Crisis Draws Privacy Concern

New Jersey is the latest state amid a national opioid crisis to consider allowing police and law enforcement officials to access its prescription drug monitoring database without a court order, pitting patient rights to privacy against the government's ability to investigate so-called doctor shopping. (Catalini, 7/23)

Boston Globe: Key Part Of Opioid Legislation Is Not Working

As originally proposed by Governor Charlie Baker, the law would have required those taken to the emergency room after an overdose to be held involuntarily for up to 72 hours to receive treatment. But the final version approved by the Legislature excised that requirement, dictating instead that hospitals must simply offer substance abuse treatment to these patients after a voluntary assessment. (Edmondson, 7/23)

Richmond Times-Dispatch: Virginia Prepared To Launch Local Needle Exchange Programs To Stanch Rising Rates Of Hepatitis C

On July 1, a new law legalizing syringe services programs — also known as needle exchanges — went into effect, but none has yet been started. The state Department of Health is awaiting applications from eligible jurisdictions before implementing the programs. (O'Connor, 7/24)

Denver Post: Colorado Medicaid Program Reduces Opioid Dosages To Combat Addiction

Colorado’s Medicaid program is reducing the amount of opioid painkillers it allows its recipients to receive, part of a growing campaign to restrict how many of the highly addictive drugs are in circulation. The new policy, announced this month, will roll out in two phases. The first, which goes into place in August, applies to Medicaid recipients who are prescribed opioids for the first time in at least a year. The policy will limit those patients to receiving only a seven-day supply to start, with two additional one-week refills possible if the patient requests them. Another refill request beyond that will require additional scrutiny. (Ingold, 7/24)

The CT Mirror: Two Who Should Know: Too Few Resources To Meet Litchfield County’s Addiction Epidemic

The need for drug and alcohol treatment services is growing in Connecticut, compounded by a dramatic increase in the number of drug and opioid cases. ...From 2014 to 2015 the drug overdose death rate increased by more than 25 percent in Connecticut, according to the Centers for Disease Control. (Werth, 7/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF